New heart failure drug aims for better fluid control without Over-Drying
NCT ID NCT04438213
Summary
This study is testing whether a medication called ertugliflozin helps people with chronic heart failure manage their body fluid levels better than a standard water pill or a placebo. Researchers will compare how these treatments, when added to a patient's usual diuretic, affect blood volume and sodium removal over six weeks. The goal is to find a way to reduce harmful fluid buildup without causing dehydration or other complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yale School of Medicine
RECRUITINGNew Haven, Connecticut, 06510, United States
Contact
Conditions
Explore the condition pages connected to this study.